advertisement

Topcon

Your Special Attention For IGR 6-1

Risk and risk factors for blindness from glaucoma

P.P. Chen
Current Opinion in Ophthalmology 2004; 15: 107-111

Abstract no. 16

"Being an average citizen is the greatest risk factor; other risk factors such as advanced visual loss and non-compliance are obvious"


Ophthalmic fundus imaging: today and beyond

L.A. Yannuzzi, M.D. Ober, J.S. Slakter, R.F. Spaide, Y.L. Fisher, R.W. Flower and R. Rosen
American Journal of Ophthalmology 2004; 137: 511-524

Abstract no. 173

"What's new in imaging a.o. a combination of scanning laser ophthalmoscopy and OCT, etc., etc.."


A review of the influence of aqueous humor on immunity

A. Taylor
Ocular Immunology and Inflammation 2003; 11: 231-241

Abstract no. 46

"The immune-privileged aqueous humor is active in immunoregulation. There is more in the aqueous humor than we thought."


The genetic loci of open-angle glaucoma

M.K. Wirtz and J.R. Samples
Ophthalmology Clinics of North America 2003; 16: 505-514

Abstract no. 110

"The final goal of genetic research is the identification of the causal genes in the patient, to aid the ophthalmologist in predicting the outcome, in determining diligent treatment is required, and ultimately, in providing the tools for preventing blindness." 


Predictive DNA testing for glaucoma: reality in 2003

D.A. Mackey and J.E. Craig
Ophthalmology Clinics of North America 2003; 16: 639-645

Abstract no. 19

"Myocilin gene testing can and should be offered for young-onset severe glaucoma cases with a positive family history." 


Avoiding and managing complications of glaucoma drainage implants

Q.H. Nguyen
Current Opinion in Ophthalmology 2004; 15: 147-150

Abstract no. 376

"Most complications seen in glaucoma drainage implants are self-resolving and rarely threaten visual outcome."


Corneal thickness in glaucoma screening, diagnosis, and management

J.D. Brandt 
Current Opinion in Ophthalmology 2004; 15: 85-89
No abstract in IGR

"The absence of a widely-accepted algorithm for the correction of IOP measurements should not prevent the widespread adoption of pachymetry as part of the comprehensive eye exam."


The immune system and glaucoma

G. Tezel and M.B. Wax
Current Opinion in Ophthalmology 2004; 15: 80-84

Abstract no. 211

"An autoimmune component, resulting from a failure to properly control aberrant, stress-induced immune response, likely accompanies the progression of neurodegeneration in glaucoma in some patients."


The dawn of genetic testing for glaucoma

C.S. Cohen and R.R. Allingham
Current Opinion in Ophthalmology 2004; 15: 75-79

Abstract no. 96

"Currently available tests for disease-related tests in patients with glaucoma or at risk for this disease remain controversial."


Does Sex Matter in Glaucoma?

E.J. Higginbotham
Archives of Ophthalmology 2004; 122: 374-375
No abstract in IGR

"All you always wanted to know about sex and glaucoma. Not that much is clear though."


Interventions for normal tension glaucoma

T. Sycha, C. Vass, O. Findl, P. Bauer, I. Groke, L. Schmetterer and H. Eichler 
Cochrane Database Syst Rev. 2003; 4: CD002222

Abstract no. 215

"Only eight studies found, one mentioned in conclusion; is that all there is?"


Optical coherence tomography to detect and manage retinal disease and glaucoma

G.J. Jaffe and J. Caprioli
American Journal of Ophthalmology 2004; 137: 156-169

Abstract no. 175

"What OCT does and does not yet. Promises for the future."


Posterior ciliary artery circulation in health and disease: the Weisenfeld lecture

S.S. Hayreh
Invest. Ophthalmol. Vis. Sci. 2004; 45: 749-757
No abstract in IGR

"Overview of the lifetime work of a giant of ciliary circulation."


Surgical strategies in patients with combined cataract and glaucoma

C. Vass and R. Menapace 
Current Opinion in Ophthalmology 2004; 15: 61-66 

Abstract no. 233

"Trab is better than phacotrab. MMC helps. Deep sclerectomy is not affected by simultaneous phaco."


Current perspectives on the TIGR/MYOC gene (Myocilin) and glaucoma

J.R. Polansky  
Ophthalmology Clinics of North America 2003; 16: 515-527

Abstract no. 109

"TIGR reported on by an afficianado with great interest."


Ganglion cell axon pathfinding in the retina and optic nerve 

S.F. Oster, M. Deiner, E. Birgbauer and D.W. Sretavan  
Seminars in Cell and Developmental Biology 2004; 15: 125-136

Abstract no. 69

"Discussion of the pathfinding tasks RGC axons face during development and the molecular mechanisms known to be involved." 


Management of late-onset bleb leaks

R.M. Feldman and G. Altaher 
Current Opinion in Ophthalmology 2004; 15: 151-154

Abstract no. 375

"Many surgical techniques are used, but none is universally successful."


Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery

P.S. Yoon and K. Singh  
Current Opinion in Ophthalmology 2004; 15: 141-146

Abstract no. 368

" The future of wound healing manipulation is promising."


Management of inflammatory glaucomas

V.C. Sung and K. Barton 
Current Opinion in Ophthalmology 2004; 15: 136-140

Abstract no. 240

"The management of uveitic glaucoma requires a careful balance between adequate anti-inflammatory therapy and appropriate intraocular pressure (IOP)-lowering to prevent long-term visual loss."


Fixed combinations of topical glaucoma medications

R.D. Fechtner and T. Realini 
Current Opinion in Ophthalmology 2004; 15: 132-135

Abstract no. 261

"Fixed combinations offer benefits of convenience, cost, and safety, but limit individualization of dosing."


Glaucoma management in developing countries: medical, laser, and surgical options for glaucoma management in countries with limited resources

R. Thomas, G.C. Sekhar and R.S. Kumar 
Current Opinion in Ophthalmology 2004; 15: 127-131

Abstract no. 264

"Views on PACG, OH and POAG in so-called developing countries. Affordable, cost-effective diagnosis and treatment is essential."


Current management of glaucoma

K. Schwartz and D. Budenz 
Current Opinion in Ophthalmology 2004; 15: 119-126

Abstract no. 263

"From medical treatment, via laser to surgery. NB cyclodestruction only as last resort."


Refractive surgery in glaucoma

T.W. Samuelson 
Current Opinion in Ophthalmology 2004; 15: 112-118

Abstract no. 201

"Although not an absolute contraindication, glaucoma is a relative contraindication, and careful patient education and life-long follow-up is mandatory."


Goldmann's equation and clinical measures of aqueous dynamics

R.F. Brubaker 
Experimental Eye Research 2004; 78: 633-637

Abstract no. 35

"Goldmann revisited."


Studies on ocular inflammation and development of a prostaglandin analogue for glaucoma treatment

J. Stjernschantz
Experimental Eye Research 2004; 78: 759-766

Abstract no. 297

"One of the fathers of latanoprost on drug development."


Cyclodestructive procedures. I. Clinical and morphological aspects: a review

F. Fankhauser, S. Kwasniewska and E. Van der Zypen 
Ophthalmologica 2004; 218: 77-95

Abstract no. 377

"If you really feel like destructing the ciliary body, here are the technical details."


Lens extraction for Angle-Closure Glaucoma

C.L. Ho, D.S. Walton and L.R. Pasquale
International Ophthalmology Clinics 2004; 44: 2130228
No abstract in IGR

"The future of ACG treatment?"


Selective laser trabeculoplasty: stimulating the meshwork to mend its ways

M.A. Latina and V. Gulati
International Ophthalmology Clinics 2004; 44: 93-103
No abstract in IGR

"On the mechanism of action of SLT"


Issue 6-1

Change Issue


advertisement

WGA Rescources